Emmes Corporation, The – Trademark Portfolio
Entity Type: 03
Emmes Corporation, The holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include EMMES and THE EMMES CORPORATION. The owner is based in Rockville, MD.
401 North Washington Street
Suite 700
Rockville, MD 20850
Showing of trademarks Trademarks
Trademark Classifications
Emmes Corporation, The's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Emmes Corporation, The have?
Emmes Corporation, The has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does Emmes Corporation, The file in?
Emmes Corporation, The files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment). Class 35 covers advertising; business management; business administration; office functions.
What are Emmes Corporation, The's most well-known trademarks?
Emmes Corporation, The's registered trademark portfolio includes well-known marks such as EMMES and THE EMMES CORPORATION. These are among 3 currently registered trademarks in the portfolio.
What is Emmes Corporation, The's trademark registration success rate?
Emmes Corporation, The has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.